DAFNA CAPITAL MANAGEMENT LLC Sage Therapeutics, Inc. Transaction History

DAFNA CAPITAL MANAGEMENT LLC portfolio value:

$7.06M
portfolio value

DAFNA CAPITAL MANAGEMENT LLC quarter portfolio value change:

+21.24%
quarter

Sage Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share 0.00% 0 shares 1.23M $39.16 180.30K
Q2 2022 share 0.00% 0 shares -144K $32.3 180.30K
Q1 2022 share 0.00% 0 shares -1.70M $33.1 180.30K
Q4 2021 share 0.00% 0 shares -319K $43.25 180.30K
Q3 2021 share Increase +5.87% 10K shares -1.68M $44.31 180.30K
Q2 2021 share Decrease -6.07% -11K shares -3.89M $56.81 170.30K
Q1 2021 share 0.00% 0 shares -2.11M $74.85 181.30K
Q4 2020 share Increase +14.53% 23K shares 6.00M $86.51 181.30K
Q3 2020 share Decrease -4.23% -7K shares 2.80M $61.12 158.30K
Q2 2020 share 0.00% 0 shares 2.12M $41.58 165.30K
Q1 2020 share Increase +32.45% 40.5K shares -4.26M $28.72 165.30K
Q4 2019 share 0.00% 0 shares -8.49M $72.19 124.80K
Q3 2019 share Increase +0.81% 1K shares -5.15M $140.29 124.80K
Q2 2019 share 0.00% 0 shares 2.97M $183.09 123.80K
Q1 2019 share Increase +18.69% 19.5K shares 9.7M $159.05 123.80K
Q4 2018 share Increase +5.03% 5K shares -4.03M $95.79 104.30K
Q3 2018 share Increase +3.44% 3.30K shares -1M $141.25 99.30K
Q2 2018 share Increase +2.13% 2K shares -114K $156.53 96K
Q1 2018 share Increase +226.39% 65.2K shares 10.39M $161.07 94K
Q4 2017 share Increase 0.00% 28.8K shares 4.74M $164.71 28.8K